Fewer deals, lower check sizes, and a smaller cohort of sector investors are the new normal. Though a new status quo has been established, founders, investors, and healthcare innovators are in different stages of acceptance and adjustment.
Some startups are avoiding the inevitable (down rounds) by pursuing unlabeled raises. Digital health’s seasoned investors are rushing to crown the next class of household-name startups. And some companies are making the tough decision to sunset their businesses; yet, their assets may live on as tuck-in acquisitions or relaunched products. The beginning of anything new can feel overwhelming and uncharted, but H1 2023’s funding data is already surfacing signals of what lies ahead for digital health innovation, Rock Health reports. Read more.
